Odefsey tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM8Y0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,344
Award facts
- Contract value 100% obligated
- $48,343.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 6, 2026, provides for the supply of Odefsey Tablet UU 30S pharmaceutical products to the Defense Logistics Agency (DLA) through a firm fixed-price contract valued at $48,343.98, with completion anticipated by January 7, 2026. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on a non-set-aside, fully competitive basis. This delivery order is issued under Amerisourcebergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally.
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. (which operates under the Amerisourcebergen business name), maintains a critical role in the federal pharmaceutical supply chain through its contracts with the DLA and other defense health agencies. The company's extensive contract portfolio demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains, from specialty medications to generic drugs, vaccines, and medical devices. This award reflects ongoing procurement activities to maintain adequate pharmaceutical inventory for military treatment facilities and defense health operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FM8Y0?
SPE2DR26FM8Y0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FM8Y0 worth?
The government has obligated $48,344 on SPE2DR26FM8Y0.
Is contract SPE2DR26FM8Y0 an order under another contract?
Yes. SPE2DR26FM8Y0 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM8Y0 competed?
The extent of competition for SPE2DR26FM8Y0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award